Overdose Prevention Through Medical Treatment of Opioid Use Disorders

  title={Overdose Prevention Through Medical Treatment of Opioid Use Disorders},
  author={Nora D. Volkow and Eric M. Wargo},
  journal={Annals of Internal Medicine},
  • N. Volkow, E. Wargo
  • Published 19 June 2018
  • Medicine, Psychology
  • Annals of Internal Medicine
In 2016, 42249 Americans fatally overdosed on an opioid (1). Although prescribing of opioid analgesics has declined thanks to greater awareness and new guidelines, increasing numbers of individuals are initiating opioid use with heroin, and nearly half of the fatal opioid overdoses in 2016 involved fentanyl and synthetic analogues. Expanding access to medications for opioid use disorder (OUD) is essential if we are to reverse these trends. The opioid agonist methadone, the partial agonist… 
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
This paper provides an overview of the literature on the availability of alcohol and opioid used disorder medications in the specialty substance use disorder treatment system, other treatment settings and systems, and among providers with a federal waiver to prescribe buprenorphine and shows steady growth in availability over the past decade and a decline in availability.
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Prevention of prescription opioid misuse alone is projected to have a modest effect on lowering opioid overdose deaths in the near future, and multipronged approach is needed to dramatically change the course of the epidemic.
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review.
Methylphenidate and Morphine Combination Therapy in a Rat Model of Chronic Pain
The data suggest that a combination therapy using low-dose MPH and MOR may produce a MOR-sparing effect in chronic pain management.


Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
This study sought to determine whether treatment with MOUD, including receipt of MMT, buprenorphine, or naltrexone, was associated with reduced risk for all-cause and opioid-related mortality.
Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants — United States, 2015–2016
From 2015 to 2016, deaths increased across all drug categories examined, and the largest overall rate increases occurred among deaths involving cocaine and synthetic opioids, likely driven by illicitly manufactured fentanyl (IMF).
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
Methadone is an effective maintenance therapy intervention for the treatment of heroin dependence as it retains patients in treatment and decreases heroin use better than treatments that do not utilise opioid replacement therapy, and does not show a statistically significant superior effect on criminal activity.
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
In this trial involving criminal justice offenders, extended-release naltrexone was associated with a rate of opioid relapse that was lower than that with usual treatment, and Opioid-use prevention effects waned after treatment discontinuation.
Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention
ED-initiated buprenorphine was associated with increased engagement in addiction treatment and reduced illicit opioid use during the 2-month interval when bupreliminary treatment was continued in primary care and HIV risk and rates of opioid-negative urine results were comparable across all groups.
Handbook of Methadone Prescribing and Buprenorphine Therapy